HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2021 PIC CONFERENCE
Search
PSYCH STOCK NEWS
CLIENT
CLINICAL TRIALS
CLINICS
CONFERENCES
DECK
INTERVIEW
INVESTORS
IPO
LARGE CAP PSYCH
NEO
PSYCH FUND | ETF
PSYCH NEWS
PSYCH STOCK NEWS
Psychedelic Investor Guide
Psychedelic Investor TV
RESEARCH
SIDE STORIES
STUFF
SUBSCRIBE
TESTIMONIALS
UNIVERSE
PharmaTher (PHRM, PHRRF) $0.10 Gets $3.80 Price Target From H.C. Wainwright...
Editor | Curator
-
July 15, 2022
Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.
Editor | Curator
-
June 22, 2022
Australian Icannex (IHL:ASX) Headed to NASDAQ?
Editor | Curator
-
February 10, 2022
Mycotopia Therapies (TPIA) $1.65, Issues CEO Letter to Stockholders, Reports on...
November 5, 2021
Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic...
November 4, 2021
Mindcure (MCURF) and Awakn Life Sciences (AWKNF) Seek to Distribute Ketamine...
October 28, 2021
Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)
October 19, 2021
Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)
October 18, 2021
Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on...
October 16, 2021
Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the...
October 15, 2021
Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida
October 13, 2021
KCSA Psychedelics Conference. Wednesday, October 13th.
October 11, 2021
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
October 2, 2021
1
2
3
...
6
Page 1 of 6
